Antibiotic price drop could stop millions from developing tuberculosis: New agreement secures 66% reduction in cost of rifapentine, which prevents ‘latent’ TB from becoming active. Available to those who could afford it, it has, until now, been “completely unaffordable” in developing countries.
Novartis arthritis drug falls short in challenge to global bestseller
Reuters: Health
Novartis said a trial fell short of producing statistical evidence that its anti-inflammatory drug Cosentyx can beat the world's best-selling drug Humira in treating a type of arthritis.
Procter & Gamble, rivals take refills into beauty aisle
Reuters: Health
Under pressure to reduce environmental waste from single-use containers, major consumer companies including Procter & Gamble Co, Unilever Plc and The Body Shop are rolling out more products in refillable form.
Schools in New Delhi shut until November 5 as air pollution severe
Reuters: Health
Schools in the Indian capital will be shut until Nov. 5, the city government said on Friday, as residents breathed the season's worst air for a third straight day.